Foot-and-Mouth Disease Virus: (i) The Biotechnological and Biomedical Utilities of the FMDV 2A Oligopeptide Sequence (ii) Developing A New Generation of Live, Attenuated, FMDV Vaccines

Activity: Talk or presentation typesInvited talk

Period2014
Held atUNIVERSITY OF NOTTINGHAM, United Kingdom